Table 1.
Sociodemographic and clinical characteristics of the studied population
| Variable | Whole group N=135 |
|---|---|
| Sex | |
| Men, n (%) | 82 (60.7) |
| Women, n (%) | 53 (39.3) |
| Age (years) | |
| M ± SD | 69.8±11.4 |
| Me (Q1; Q3) | 68 (60; 79) |
| Min–max | 50–92 |
| Age groups (years) | |
| I: 50–59, n (%) | 30 (22.2) |
| II: 60–74, n (%) | 52 (38.5) |
| III: 75–89, n (%) | 49 (36.3) |
| IV: 90–92, n (%) | 4 (3.0) |
| BMI (kg/m2) | |
| M ± SD | 26.9±4.6 |
| Me (Q1; Q3) | 26.4 (23.4; 30.1) |
| Min–max | 16.4–41.1 |
| Marital status | |
| Married, n (%) | 76 (56.3) |
| Single, n (%) | 59 (43.7) |
| Education | |
| Primary, n (%) | 23 (17.0) |
| Vocational, n (%) | 50 (37.1) |
| Secondary, n (%) | 54 (40.0) |
| Higher, n (%) | 8 (5.9) |
| Place of residence | |
| City/town, n (%) | 114 (84.4) |
| Village/country, n (%) | 21 (15.6) |
| ACS severity | |
| STEMI, n (%) | 61 (45.2) |
| NSTEMI, n (%) | 64 (47.4) |
| UA, n (%) | 10 (7.4) |
| Therapeutic interventions | |
| PCI, n (%) | 100 (74.1) |
| Qualification for CABG, n (%) | 16 (11.8) |
| Pharmacological treatment, n (%) | 19 (14.1) |
| Concomitant diseasesa | |
| Arterial hypertension, n (%) | 106 (78.5) |
| Renal malfunction, n (%) | 14 (10.4) |
| Diabetes, n (%) | 30 (22.2) |
Note:
a
The ratios do not add up to 100 since some patients suffered from more than one disease.
Abbreviations: ACS, acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass graft; M, mean; max, maximum; min, minimum; Me, Median; (Q1;Q3), (first quartile; third quartile); NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; SD, standard deviation; STEMI, ST segment elevation myocardial infarction; UA, unstable angina.